|
|
Volumn 298, Issue 1, 2007, Pages 29-30
|
|
Trials assess myasthenia gravis therapies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CHOLINERGIC RECEPTOR;
CHOLINESTERASE INHIBITOR;
CORTICOSTEROID;
CYCLOSPORIN;
ETANERCEPT;
IMMUNOGLOBULIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PLACEBO;
PREDNISONE;
TUMOR NECROSIS FACTOR ALPHA;
DRUG DERIVATIVE;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ACETYLCHOLINE RELEASE;
ACUTE GRAFT REJECTION;
ANKYLOSING SPONDYLITIS;
AUTOIMMUNE DISEASE;
BLURRED VISION;
CLINICAL TRIAL;
DRUG DOSE REDUCTION;
DYSPHAGIA;
DYSPNEA;
EYELID DISEASE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MUSCLE CONTRACTION;
MUSCLE FATIGUE;
MUSCLE WEAKNESS;
MYASTHENIA GRAVIS;
NEUROMUSCULAR SYNAPSE;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SLURRED SPEECH;
THYMECTOMY;
ARTICLE;
CLINICAL TRIALS;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
MYASTHENIA GRAVIS;
MYCOPHENOLIC ACID;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
|
EID: 34347403042
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.298.1.29 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|